Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,367Revenue (TTM) $M384Net Margin (%)-27.2Altman Z-Score18.9
Enterprise Value $M5,758EPS (TTM) $-0.8Operating Margin %-27.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-27.2Higher ROA y-yN
Price/Book9.510-y EBITDA Growth Rate %-3.7Quick Ratio5.3Cash flow > EarningsN
Price/Sales15.95-y EBITDA Growth Rate %-3.6Current Ratio5.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-13.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-17.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M141ROIC % (ttm)-879.5Gross Margin Increase y-yY

Gurus Latest Trades with SGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGENGeorge Soros 2016-06-30 Buy 0.02%$32.95 - $43.78
($37.99)
$ 45.3619%New holding14,700
SGENJoel Greenblatt 2016-06-30 Buy 0.01%$32.95 - $43.78
($37.99)
$ 45.3619%New holding30,082
SGENVanguard Health Care Fund 2015-12-31 Sold Out -0.01%$37.16 - $45.52
($41.72)
$ 45.369%Sold Out0
SGENVanguard Health Care Fund 2015-06-30 Buy 0.02%$34.03 - $49.63
($41.17)
$ 45.3610%New holding170,125
SGENFirst Eagle Investment 2010-03-31 Sold Out -0.01%$9.34 - $12.59
($10.85)
$ 45.36318%Sold Out0
SGENFirst Eagle Investment 2009-12-31 Buy 0.01%$8.74 - $13.16
($9.69)
$ 45.36368%New holding67,373
SGENBill Gates 2009-09-30 Sold Out -0.39%$8.75 - $14.8
($11.69)
$ 45.36288%Sold Out0
SGENFirst Eagle Investment 2009-06-30 Sold Out -0.01%$8.18 - $10.34
($9.11)
$ 45.36398%Sold Out0
SGENFirst Eagle Investment 2009-03-31 Add$7.23 - $10.36
($9.4)
$ 45.36383%Add 40.00%70,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DOBMEIER ERICCOO 2016-08-23Sell12,589$48-5.5view
Cline Darren SEVP, Commercial 2016-08-22Sell1,774$46.59-2.64view
DOBMEIER ERICCOO 2016-08-22Sell5,411$46.59-2.64view
DRACHMAN JONATHAN GCMO & EVP, R & D 2016-08-22Sell3,991$46.59-2.64view
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops 2016-08-22Sell3,991$46.59-2.64view
SIEGALL CLAY BPresident and CEO 2016-08-22Sell23,381$46.59-2.64view
SIMPSON TODD ECFO 2016-08-22Sell3,991$46.59-2.64view
SIEGALL CLAY BPresident and CEO 2016-08-08Sell11,660$47.19-3.88view
SIEGALL CLAY BPresident and CEO 2016-07-27Sell4,042$45.20.35view
SIEGALL CLAY BPresident and CEO 2016-07-06Sell7,618$40.5611.83view

Quarterly/Annual Reports about SGEN:

News about SGEN:

Articles On GuruFocus.com
Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
Top Insider Trades of the Past Week Feb 19 2016 
Insiders Are Buying Barnes & Noble Sep 18 2015 
Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 
Insiders keep on buying Macerich Co and Seattle Genetics May 22 2015 
Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA May 12 2015 
Seattle Genetics: Can Record Growth From Its Licenses Oct 28 2014 
Seattle Genetics: Can Record Sustained Growth From Royalty Aug 31 2014 
Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 

More From Other Websites
[$$] Seattle Genetics Stock Surges, Execs Sell Aug 26 2016
ETF’s with exposure to Seattle Genetics, Inc. : August 25, 2016 Aug 25 2016
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss Aug 23 2016
ETF’s with exposure to Seattle Genetics, Inc. : August 9, 2016 Aug 09 2016
Seattle Genetics, Inc. :SGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 Aug 08 2016
Bloomberg TVs' Doolittle Breaks Down Nasdaq Biotech Movers Aug 01 2016
SEATTLE GENETICS INC /WA Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 01 2016
Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS®... Aug 01 2016
Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS®... Aug 01 2016
Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS®... Aug 01 2016
SEATTLE GENETICS INC /WA Financials Jul 30 2016
Delving Into Seattle Genetics, Inc. (SGEN)’s Upcoming Readout Jul 28 2016
Seattle Genetics' (SGEN) Loss Narrower than Expected in Q2 Jul 27 2016
Seattle Genetics downgraded by Cantor Fitzgerald Jul 27 2016
Edited Transcript of SGEN earnings conference call or presentation 26-Jul-16 8:30pm GMT Jul 27 2016
Seattle Genetics reports 2Q loss Jul 26 2016
Seattle Genetics reports 2Q loss Jul 26 2016
Seattle Genetics reports 2Q loss Jul 26 2016
SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 26 2016
Seattle Genetics Reports Second Quarter 2016 Financial Results Jul 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)